Combination immunogene therapy
AssigneeAMDL, Inc.
InventorLung-Ji Chang
Life of this patent
Estimating the term…
Abstract
The present invention provides to immunogene therapy protocols for the treatment of tumors. In particular, the present invention provides combinations of immune-modulating proteins that induce systemic immunity against tumors. In addition, the present invention provides humanized animal models suitable for the evaluation of anti-human tumor immunity and permit the identification of combinations of immune-modulating genes which when delivered to human tumor cells induce an effective anti-tumor response, including a systemic anti-tumor response.
Claims8
An expression vector comprising a polynucleotide sequence encoding a B7-2 protein and at least one additional immune modulating protein.
Dependencies are inferred from the claim text.